Accent Microcell Limited specializes in manufacturing cellulose-based excipients primarily used in pharmaceuticals, nutraceuticals, food, and cosmetics. Their core products include Microcrystalline Cellulose (MCC), Spray Dried MCC, and Silicified Microcrystalline Cellulose (SMCC).

The company has a robust export footprint, contributing to over 53% of its revenue, indicating a strong presence in international markets. It has embarked on a strategic expansion to scale production and diversify product offerings.

Accent is expanding its production capacity by establishing a third manufacturing facility with the ability to produce premium excipients like CCS, SSG, and CMC. Expected commercial operations are targeted by mid-2025.

The company has sustained financial growth with revenues topping ₹265 crore in FY 2025 and an expected increase in profitability through higher-margin products.

Accent has maintained a strong financial foundation with decreased borrowings and strategic plans to utilize internal accruals for its expansion, reflecting solid financial and operational management.